Neural Stimulation for Hand Grasp in People With Tetraplegia
AGILIS
Functional Evaluation of the Recovery of Prehension in Persons With Tetraplegia by Implanted Neural Stimulation
1 other identifier
interventional
2
1 country
1
Brief Summary
A selective neural stimulation as the investigators propose allows to stimulate several muscles via a single electrode. Neural stimulation requires less energy for muscle activation. In our approach, 2 electrodes will be implanted above the elbow on the median, the ulnar and the radial nerves. This considerably reduces the number of implanted elements and therefore i) the risk of infection, ii) the risk of failure, iii) the surgical risk through minimally invasive surgery. Our main hypothesis is that multipolar neural electrical stimulation of the median and the ulnar nerve (flexion) and the radial nerve (extension) allows:
- on the one hand, a selective, individualized motor activation (muscle by muscle)
- on the other hand, a synergistic motor activation (association of several muscles) for the purpose of production of functional movements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2022
CompletedFirst Posted
Study publicly available on registry
September 27, 2022
CompletedStudy Start
First participant enrolled
October 10, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJanuary 29, 2024
October 1, 2022
1.1 years
August 29, 2022
January 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional outcome: Number of successful trials (task completed) out of 5 trials with 5 preselected objects.
The objective is to show that neural electrical stimulation allows the user to master the completion of each of pre-selected gripping tasks. The evaluation criteria is the number of successful trials (task completed) out of 5 trials with 5 preselected objects. For each object, a successful gripping task is a task completed in a duration \<180 sec.
Baseline prior to surgery and following surgery: Day5, Day6, Day8, Day12, Day15, Day17, Day22, Day26 and Day29
Secondary Outcomes (7)
Functional outcome
Following surgery from Day12: Day12, Day15, Day17, Day22, Day26 and Day29
Strength
Baseline prior to surgery and following surgery: Day5, Day6, Day8, Day12, Day15, Day17, Day22, Day26 and Day29
Fatigue
Baseline prior to surgery and following surgery: Day5, Day6, Day8, Day12, Day15, Day17, Day22, Day26 and Day29
Self perception and psychological well being
Baseline prior to surgery and following surgery: Day8, Day15, Day22, Day29
System Usability Scale
Following surgery : Day8 and Day29
- +2 more secondary outcomes
Study Arms (1)
Neurostimulation
EXPERIMENTALImplantation of 3 multicontact cuff electrodes in the upper limb of patients with tetraplegia
Interventions
Implantation of 3 multicontact cuff electrodes in the upper limb of patients with tetraplegia and control of the stimulation by contralateral shoulder movements
Eligibility Criteria
You may qualify if:
- Informed consent signed
- Patient affiliated to a social security (state medical aid excepted).
- Neurological level ≥ C7 4.18 years old ≤ age ≤ 65 years old,
- complete traumatic injury: defined by an A or B score on the AIS scale. (AIS A or - complete motor deficit under injury. This is an internationally agreed standard for describing spinal cord injury) 6.neurological stability (no change in muscle testing) \> 6 months, 7.post-injury duration \> 6 months 8.patients without active muscle resources for conventional tendon transfer surgery on the forearm and hand
You may not qualify if:
- patient deprived of liberty (by judicial or administrative decision).
- adult patient who is subject to a legal protection measure or unable to express consent
- participation in another ongoing clinical trial
- pregnant or breastfeeding women or women of childbearing age without effective contraception
- spasticity and contractures in flexion or extension of the upper limbs of a destabilizing nature.
- unstable epilepsy with a notion of a epileptic seizure that occurred within the previous 12 months.
- unstable cardiovascular pathology (coronary heart disease, major hypertension, heart failure, etc.).
- wearing a pacemaker or a spinal cord stimulator implant
- dermatological problems contraindicating the application of surface electrodes.
- body weight \>100 kg
- psychiatric condition and/or history contraindicating participation in research
- any contraindications to anesthesia and/or surgery
- hypersensitivity to low molecular weight heparin (LMWH) or to any of the excipients of the specialty used
- history of immune-mediated heparin-induced thrombocytopenia (HIT) within the last 100 days or presence of circulating antibodies
- clinically significant active bleeding or a condition associated with a high risk of bleeding
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Bouffard Vercelli - USSAPlead
- Institut National de Recherche en Informatique et en Automatiquecollaborator
- NEURINNOVcollaborator
Study Sites (1)
Rehabilitation Center Bouffard-Vercelli USSAP
Perpignan, 66000, France
Related Publications (1)
Fattal C, Teissier J, Geffrier A, Fonseca L, William L, Andreu D, Guiraud D, Azevedo-Coste C. Restoring Hand Functions in People with Tetraplegia through Multi-Contact, Fascicular, and Auto-Pilot Stimulation: A Proof-of-Concept Demonstration. J Neurotrauma. 2022 May;39(9-10):627-638. doi: 10.1089/neu.2021.0381. Epub 2022 Feb 2.
PMID: 35029125RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles FATTAL, MD, PhD
Centre Bouffard Vercelli - USSAP
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2022
First Posted
September 27, 2022
Study Start
October 10, 2022
Primary Completion
November 30, 2023
Study Completion
December 31, 2023
Last Updated
January 29, 2024
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share